Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study investigators changed institution
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The brain is a very vulnerable organ, especially in premature babies, newborns and infants. However, during anesthesia, the oxygenation of the brain can only be monitored indirectly and insufficiently. Near-infrared spectroscopy (NIRS) is an established monitoring method in other areas (e.g., neonatology, cardiac anesthesia), which provides non-invasive information about the regional oxygen supply of the brain. The integration of this monitoring device into the anaesthesiological care for neonates and infants could reduce the risk of cerebral hypoxia. The planned study investigates whether the use of NIRS in anesthetized children up to 6 months can prevent or influence the occurrence of cerebral hypoxia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| NIRS open | Experimental | Cerebral NIRS monitoring applied and visible to caregiver. Interventions according to protocol in phases of cerebral hypoxia |
|
| NIRS blinded | No Intervention | NIRS monitoring applied and masked for caregiver. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NIRS open | Diagnostic Test | Treatment according to protocol in phases of cerebral hypoxia. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cerebral hypoxic burden | Time under 65% cerebral oxygen saturation | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Fluid administration | ml/kg | 1 day |
| Number of participants with Vasopressor or Inotrope administered | Proportion | 1 day |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stefan Heschl, M.D., Ph.D. | Medical University of Graz | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Number of participants with erythrocyte administration | Proportion | 1 day |
| Fraction of inspired oxygen | % | 1 day |